119 related articles for article (PubMed ID: 19321874)
1. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
Jourde N; Mancini J; Chiche L
N Engl J Med; 2009 Mar; 360(13):1358; author reply 1359. PubMed ID: 19321874
[No Abstract] [Full Text] [Related]
2. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
Gelber AC
N Engl J Med; 2009 Mar; 360(13):1358-9; author reply 1359. PubMed ID: 19330939
[No Abstract] [Full Text] [Related]
3. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
Pagnoux C; Mahr A; Hamidou MA; Boffa JJ; Ruivard M; Ducroix JP; Kyndt X; Lifermann F; Papo T; Lambert M; Le Noach J; Khellaf M; Merrien D; Puéchal X; Vinzio S; Cohen P; Mouthon L; Cordier JF; Guillevin L;
N Engl J Med; 2008 Dec; 359(26):2790-803. PubMed ID: 19109574
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
Tervaert JW; Stegeman CA
Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
[TBL] [Abstract][Full Text] [Related]
5. Necrotizing vasculitis--a 2009 update.
Sharaf PH; Yazici Y
Bull NYU Hosp Jt Dis; 2009; 67(3):303-5. PubMed ID: 19852754
[TBL] [Abstract][Full Text] [Related]
6. Probable psychiatric side effects of azathioprine.
van der Hoeven J; Duyx J; de Langen JJ; van Royen A
Psychosom Med; 2005; 67(3):508. PubMed ID: 15911917
[No Abstract] [Full Text] [Related]
7. When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy?
Flossmann O; de Groot K
Nat Clin Pract Nephrol; 2007 May; 3(5):236-7. PubMed ID: 17457358
[No Abstract] [Full Text] [Related]
8. Clinical features and outcome of pediatric Wegener's granulomatosis.
Akikusa JD; Schneider R; Harvey EA; Hebert D; Thorner PS; Laxer RM; Silverman ED
Arthritis Rheum; 2007 Jun; 57(5):837-44. PubMed ID: 17530684
[TBL] [Abstract][Full Text] [Related]
9. [Wegener's granulomatosis and microscopic polyangiitis].
Pagnoux C
Rev Prat; 2008 Mar; 58(5):522-32. PubMed ID: 18524109
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
Jayne D; Rasmussen N; Andrassy K; Bacon P; Tervaert JW; Dadoniené J; Ekstrand A; Gaskin G; Gregorini G; de Groot K; Gross W; Hagen EC; Mirapeix E; Pettersson E; Siegert C; Sinico A; Tesar V; Westman K; Pusey C;
N Engl J Med; 2003 Jul; 349(1):36-44. PubMed ID: 12840090
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis.
Lurati-Ruiz F; Spertini F
J Rheumatol; 2005 Nov; 32(11):2167-72. PubMed ID: 16265696
[TBL] [Abstract][Full Text] [Related]
12. Nasal ulcers in the ED: from Wegener's granulomatosis.
Johnson R; Crisham M
Am J Emerg Med; 2005 Oct; 23(6):817-9. PubMed ID: 16182998
[No Abstract] [Full Text] [Related]
13. Primary systemic vasculitis.
Day C; Savage C
Minerva Med; 2001 Oct; 92(5):349-63. PubMed ID: 11675579
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney.
Yu F; Chen M; Wang SX; Zou WZ; Zhao MH; Wang HY
Nephrology (Carlton); 2007 Feb; 12(1):74-80. PubMed ID: 17295665
[TBL] [Abstract][Full Text] [Related]
15. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.
Metzler C; Miehle N; Manger K; Iking-Konert C; de Groot K; Hellmich B; Gross WL; Reinhold-Keller E;
Rheumatology (Oxford); 2007 Jul; 46(7):1087-91. PubMed ID: 17519271
[TBL] [Abstract][Full Text] [Related]
16. Treatment of ANCA-associated vasculitis.
Langford CA
N Engl J Med; 2003 Jul; 349(1):3-4. PubMed ID: 12840085
[No Abstract] [Full Text] [Related]
17. [Immunosuppressive therapy of Wegener's granulomatosis].
Duck HJ; Rosenkranz M; Rogos R
Z Gesamte Inn Med; 1971 Oct; 26(20):639-44. PubMed ID: 5004144
[No Abstract] [Full Text] [Related]
18. Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis.
Choi HK; Merkel PA; Tervaert JW; Black RM; McCluskey RT; Niles JL
Arthritis Rheum; 1999 Feb; 42(2):384-8. PubMed ID: 10025935
[TBL] [Abstract][Full Text] [Related]
19. [New therapeutic strategies in ANCA-associated systemic vasculitis].
Ruiz FL; Bart PA
Rev Med Suisse; 2005 Jan; 1(1):19-23. PubMed ID: 15773192
[TBL] [Abstract][Full Text] [Related]
20. TNF-alpha bioactivity-inhibiting therapy in ANCA-associated vasculitis: clinical and experimental considerations.
Huugen D; Tervaert JW; Heeringa P
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1100-7. PubMed ID: 17699331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]